-
PMV Pharma NASDAQ:PMVP PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
Location: | Website: pmvpharma.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-118M
Cash
212.9M
Avg Qtr Burn
-11.38M
Short % of Float
2.72%
Insider Ownership
2.31%
Institutional Own.
84.22%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Rezatapopt/ PC14586 (p53 reactivator) Details Solid tumor/s, Cancer | Phase 2 Data readout | |
Rezatapopt/ PC14586 (p53 reactivator) + KEYTRUDA Details Solid tumor/s, Cancer | Phase 1b Data readout |